Skip to main content

Colony-stimulating factor use in the context of refined risk and benefit assessments.

Publication ,  Journal Article
Crawford, J
Published in: Oncology (Williston Park)
April 2006

Duke Scholars

Published In

Oncology (Williston Park)

ISSN

0890-9091

Publication Date

April 2006

Volume

20

Issue

5 Suppl 4

Start / End Page

9 / 10

Location

United States

Related Subject Headings

  • Risk Assessment
  • Recombinant Proteins
  • Neutropenia
  • Neoplasms
  • Humans
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Granulocyte Colony-Stimulating Factor
  • Filgrastim
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Crawford, J. (2006). Colony-stimulating factor use in the context of refined risk and benefit assessments. Oncology (Williston Park), 20(5 Suppl 4), 9–10.
Crawford, Jeffrey. “Colony-stimulating factor use in the context of refined risk and benefit assessments.Oncology (Williston Park) 20, no. 5 Suppl 4 (April 2006): 9–10.
Crawford J. Colony-stimulating factor use in the context of refined risk and benefit assessments. Oncology (Williston Park). 2006 Apr;20(5 Suppl 4):9–10.
Crawford, Jeffrey. “Colony-stimulating factor use in the context of refined risk and benefit assessments.Oncology (Williston Park), vol. 20, no. 5 Suppl 4, Apr. 2006, pp. 9–10.
Crawford J. Colony-stimulating factor use in the context of refined risk and benefit assessments. Oncology (Williston Park). 2006 Apr;20(5 Suppl 4):9–10.

Published In

Oncology (Williston Park)

ISSN

0890-9091

Publication Date

April 2006

Volume

20

Issue

5 Suppl 4

Start / End Page

9 / 10

Location

United States

Related Subject Headings

  • Risk Assessment
  • Recombinant Proteins
  • Neutropenia
  • Neoplasms
  • Humans
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Granulocyte Colony-Stimulating Factor
  • Filgrastim